Bionostics

Investment date February 2008
Exit date August 2013
Sector Health services
Deal type Public-to-private
Exit type Trade sale
Total investment £15.7 million
Realised proceeds £62.0 million

Investment overview

Bionostics was an industry-leading developer, manufacturer and distributor of liquid control solutions employed in medical diagnostic testing equipment. Bionostics' blood glucose and blood gas control solutions were supplied to pharmaceutial OEMs and direct to hospitals.